ArticleBone marrow transplantation2026

Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with cutaneous T-cell lymphoma.

Isabelle Krämer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.